We determine the optimal health policy mix when the average utility of patients increases with the supply of drugs available in a therapeutic class. Health risk coverage rely on two instruments, copayment and reference pricing, that affect the supported risk composed by health expenses and...

We determine the optimal health policy mix when the average utility of patients increases with the supply of drugs available in a therapeutic class. Health risk coverage rely on two instruments, copayment and reference pricing, that affect the supported risk composed by health expenses and...

Using detailed daily information covering 100 countries and an event-study approach, we estimate the short run effects of implementing Non-Pharmaceutical Interventions (NPIs) on the spread of the COVID-19 virus at the early stages of the pandemic. We study the impact of two NPIs -stay-at-home...